Ingenito Gary's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Dec 8, 2021
- Accession no.
- 0001161697-21-000569
- Filed
- Dec 8, 2021
- Trade date
- Dec 7, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $25.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ingenito GaryCIK 0001279473 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Common Stock | MOption exerciseAcquired | +14,667 | $0.00 | $0 | 1,056,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Referenced by the price of 1 transaction in Table I.
- F2
Dr. Ingenito sold the shares on the open market to pay for taxes due on the vesting of the restricted stock units and not as a result of any disagreement with the Registrant. Dr. Ingenito remains an officer of the Company.
Referenced by the price of 1 transaction in Table I.